To hear about similar clinical trials, please enter your email below
Trial Title:
Cutaneous Squamous Cell Carcinoma Staging Study
NCT ID:
NCT05695222
Condition:
Cutaneous Squamous Cell Carcinoma
Conditions: Official terms:
Carcinoma
Carcinoma, Squamous Cell
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Other
Intervention name:
This is not an interventional study
Description:
This is not an interventional study
Summary:
Cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer,
and one of the most common cancers worldwide. The majority of CSCCs are easily removed by
surgery and have excellent prognosis. However, a small subset has poor outcomes,
including secondary spread in the body (metastasis) and death.
The investigators will look at existing CSCC in people from two UK dermatology centres.
The investigators will then evaluate the accuracy of current staging systems in
predicting risk of poor outcomes in people. The investigators hope that this project will
improve the management of patients with CSCC by validating the predictive power of
currently available histological staging classifications for cSCC. In the second stage of
the study, The investigators will see whether better prediction tools can be found.
Criteria for eligibility:
Study pop:
Patients treated at two tertiary Dermatology centers
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Over 18 years old with diagnosis of CSCC
Exclusion Criteria:
- Patients who decline for their data to be used for research purposes
Gender:
All
Minimum age:
18 Years
Maximum age:
120 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Dr Emilia Peleva
Address:
City:
London
Country:
United Kingdom
Start date:
May 1, 2023
Completion date:
November 2024
Lead sponsor:
Agency:
Queen Mary University of London
Agency class:
Other
Source:
Queen Mary University of London
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05695222
